CarePointer AB: public contracts won without a rival in Sweden

Updated 17 October 2026 · 2025-08-19 to 2026-03-30 · all of Sweden · record in the register

CarePointer AB: public contracts won without a rival in Sweden: 1 uncontested awards; 14% of its awards; 0 without a competition; 1 single bid.

Assay record ASY-SE-00YV5FF1B1 · Cite as: Assay Systems, “CarePointer AB: public contracts won without a rival in Sweden”, https://assay-systems.com/register/se/uncontested/s/carepointer-ab/

1
1uncontested awards
14%of its awards
0without a competition
1single bid

CarePointer AB won 1 of its 7 public contract awards in Sweden without a rival from 2025-08-19 to 2026-03-30: 0 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Region Stockholm - Serviceförvaltningen with 1.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

Region Stockholm - Serviceförvaltningen1uncontested7awards14%of these awards

Region Stockholm - Serviceförvaltningen gave CarePointer AB 7 awards: 0 without a competition, 1 after a competition with a single bid. First 2025-08-19, latest 2026-03-30.

Latest awards without a rival

DateBuyerHowStated reason
2025-12-19Region Stockholm - Serviceförvaltningen
847093-2025
Single bid
restricted
—

Every uncontested award in Sweden · All countries · CarePointer AB in the register

Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.